Alumis Inc
NASDAQ:ALMS
Alumis Inc
NASDAQ:ALMS
Price:
6.46
USD
-2.42%
Market Cap:
$836.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for ALMS
There is not enough data to reliably calculate the intrinsic value for Alumis Inc.
Do our valuations actually work? See backtest results .
Alternatives to ALMS
Fundamental Analysis
What Alumis Does
Alumis Inc. is a biotechnology company focused on developing medicines for immune-related diseases, especially conditions where the body’s immune system attacks healthy tissue. Its work centers on creating small-molecule drugs that can be taken by mouth and are designed to control inflammation more precisely than older treatments.
- Headquarters
- United States of America US
- Employees
- 221
- IPO date
- Jun 28, 2024
Financials
Efficiency
Earnings Waterfall
Alumis Inc
Alumis Inc
